Owners, management and financials
CVR: 20601116
Secondary names: ERCOPHARM A/S
DKK 329,561,856
Revenue
Net result: DKK 10,525,947
Orion Corporation (100%)
CVR · view owners
Jesper Otto Qvist-Pedersen
Board: Satu Maarit Ahomäki (chair) and 2 members
CVR · view management
Active
Founded 16 February 1953
CVR · view overview
29 employees
CVR · 2018
Director registered: Jesper Otto Qvist-Pedersen
CVR · 01/11/2015
View the full event history
ORION PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1953. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jesper Otto Qvist-Pedersen. The board consists of Satu Maarit Ahomäki (chair), Mikko Tapani Kemppainen and René Kristian Lindell. The company is owned by Orion Corporation. The company has 29 employees (2018). In 2025, the company reported revenue of DKK 329,561,856 and a net result of DKK 10,525,947 compared with DKK 10,899,639 the year before. Equity in the 2025 report amounted to DKK 32,510,625.
Source: annual report 2025, Danish Business Authority
The financial health of ORION PHARMA A/S appears stable, with a notable upward trend in revenue over the past few years. Revenue increased from 214.2 million DKK in 2022 to 329.6 million DKK in 2025, while profit also rose from 4.5 million DKK in 2021 to 10.5 million DKK in 2025, indicating improved profitability. However, equity has fluctuated, peaking at 51.7 million DKK in 2023 before declining to 32.5 million DKK in 2025, which may raise concerns about financial stability. Overall, the company is positioned well within the pharmaceutical wholesale industry, benefiting from growing demand for medicinal products and healthcare supplies.
AI-generated summary · Generated 28/05/2026
Selskabets formål er at drive handel, derunder import og eksport samt agenturvirksomhed med kemiske og pharmaceutiske produkter, medicinalvarer, artikler til sådanne frembringelser.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 329.6 mio. | 10.5 mio. | 88.5 mio. | 32.5 mio. | 14 | |
| 202401/01/2024 – 31/12/2024 | 309 mio. | 10.9 mio. | 70.4 mio. | 32 mio. | 15 | |
| 202301/01/2023 – 31/12/2023 | 253.1 mio. | 8.2 mio. | 89.6 mio. | 51.7 mio. | 16 | |
| 202201/01/2022 – 31/12/2022 | 214.2 mio. | 7.5 mio. | 83.1 mio. | 50.5 mio. | 16 | |
| 202101/01/2021 – 31/12/2021 | 212.5 mio. | 4.5 mio. | 86.7 mio. | 47.9 mio. | 17 | |
| 202001/01/2020 – 31/12/2020 | 282.9 mio. | 6.3 mio. | 93.9 mio. | 51.4 mio. | 20 | |
| 201901/01/2019 – 31/12/2019 | 280.9 mio. | 16.9 mio. | 95.5 mio. | 57.6 mio. | 24 | |
| 201801/01/2018 – 31/12/2018 | 247.1 mio. | 20.5 mio. | 86.7 mio. | 50.7 mio. | 28 | |
| 201701/01/2017 – 31/12/2017 | 327.7 mio. | 37.8 mio. | 131.6 mio. | 95.2 mio. | 29 | |
| 201601/01/2016 – 31/12/2016 | 373.7 mio. | 56.7 mio. | 162.4 mio. | 97.3 mio. | 29 | |
| 201501/01/2015 – 31/12/2015 | 273 mio. | 44.8 mio. | 122.4 mio. | 66.6 mio. | 28 | |
| 201401/01/2014 – 31/12/2014 | 166.9 mio. | 24.7 mio. | 76.3 mio. | 46.8 mio. | 31 | |
| 201301/01/2013 – 31/12/2013 | 164.8 mio. | 25.6 mio. | 72.4 mio. | 39.1 mio. | 33 |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
10 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of ORION PHARMA A/S is 20601116.
ORION PHARMA A/S is owned by Orion Corporation.
The management of ORION PHARMA A/S consists of Jesper Otto Qvist-Pedersen.
The board of ORION PHARMA A/S consists of Satu Maarit Ahomäki, Mikko Tapani Kemppainen and René Kristian Lindell, with Satu Maarit Ahomäki as chair.
In 2025, ORION PHARMA A/S reported revenue of DKK 329,561,856.
ORION PHARMA A/S had 29 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
ORION PHARMA A/S has published its annual report for 2025. Revenue came to DKK 329,561,856, and the net result was DKK 10,525,947.
ORION PHARMA A/S has won the tender "Amgros 2026 1.1482.b" issued by Amgros I/S worth 1,057,200,000 DKK.
ORION PHARMA A/S has won the tender "Amgros 2026 2.1390.b" issued by Amgros I/S worth 23,945,273 DKK.
ORION PHARMA A/S has won the tender "Amgros 2026 1.617.b" issued by Amgros I/S worth 43,827,250 DKK.
ORION PHARMA A/S has won the tender "Amgros 2026 2.212.a" issued by Amgros I/S worth 10,566,595 DKK.
ORION PHARMA A/S has won the tender "Amgros 2026 1.701.a" issued by Amgros I/S worth 1,428,533,153 DKK.
ORION PHARMA A/S has published its annual report for 2024. Revenue came to DKK 309,011,374, and the net result was DKK 10,899,639.
As of February 10, 2025, Mikko Tapani Kemppainen has joined the board of directors of ORION PHARMA A/S.
As of February 10, 2025, Satu Maarit Ahomäki has joined the board of directors of ORION PHARMA A/S.
As of February 10, 2025, Olli Heikki Huotari has left the board of directors of ORION PHARMA A/S.
As of February 9, 2025, Satu Maarit Ahomäki has left the board of directors of ORION PHARMA A/S.
ORION PHARMA A/S has won the tender "Amgros 2025 2.212.a" issued by Amgros I/S worth 14,666,754 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.1391.b" issued by Amgros I/S worth 74,708,177 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.700.a" issued by Amgros I/S worth 313,301,544 DKK.
ORION PHARMA A/S has won the tender "Amgros 2025 1.1305.a" issued by Amgros I/S worth 91,145,340 DKK.
ORION PHARMA A/S has won the tender "Joint Nordic Procurement of Pharmaceuticals - 2025 - NF2.1301.a" issued by Amgros I/S worth 227,000,000 EUR.
ORION PHARMA A/S has published its annual report for 2023. Revenue came to DKK 253,050,082, and the net result was DKK 8,232,002.
As of April 22, 2024, René Kristian Lindell has joined the board of directors of ORION PHARMA A/S.
As of April 22, 2024, Jari Ilmari Karlson has left the board of directors of ORION PHARMA A/S.
ORION PHARMA A/S has published its annual report for 2022. Revenue came to DKK 214,174,882, and the net result was DKK 7,529,338.
ORION PHARMA A/S has published its annual report for 2021. Revenue came to DKK 212,530,416, and the net result was DKK 4,513,431.
ORION PHARMA A/S has published its annual report for 2020. Revenue came to DKK 282,867,433, and the net result was DKK 6,315,388.
ORION PHARMA A/S has published its annual report for 2019. Revenue came to DKK 280,861,600, and the net result was DKK 16,907,454.
ORION PHARMA A/S has published its annual report for 2018. Revenue came to DKK 247,118,144, and the net result was DKK 20,524,490.
As of September 17, 2018, KPMG P/S has been appointed auditor of ORION PHARMA A/S.
As of September 17, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ORION PHARMA A/S.
ORION PHARMA A/S has published its annual report for 2017. Revenue came to DKK 327,737,984, and the net result was DKK 37,821,319.
ORION PHARMA A/S has published its annual report for 2016. Revenue came to DKK 373,655,929, and the net result was DKK 56,727,015.
ORION PHARMA A/S has published its annual report for 2015. Revenue came to DKK 272,966,662, and the net result was DKK 44,821,782.
As of November 1, 2015, Jesper Otto Qvist-Pedersen is registered as adm. dir. of ORION PHARMA A/S.
As of October 31, 2015, Kaisa Tarkkanen has stepped down as adm. dir. of ORION PHARMA A/S.
ORION PHARMA A/S has published its annual report for 2014. Revenue came to DKK 166,850,619, and the net result was DKK 24,675,624.
ORION PHARMA A/S has published its annual report for 2013. Revenue came to DKK 164,778,384, and the net result was DKK 25,585,348.
ORION PHARMA A/S has published its annual report for 2012.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ORION PHARMA A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of ORION PHARMA A/S.
As of February 24, 2011, Satu Maarit Ahomäki has joined the board of directors of ORION PHARMA A/S.
As of February 24, 2011, Pekka Mikael Kaivola has left the board of directors of ORION PHARMA A/S.
As of March 20, 2008, A/S PSE NR. 4820 has been appointed auditor of ORION PHARMA A/S.
As of March 20, 2008, EY Danmark A/S has stepped down as auditor of ORION PHARMA A/S.
As of November 1, 2006, Kaisa Tarkkanen is registered as adm. dir. of ORION PHARMA A/S.
As of November 1, 2006, Tomas Olof Leander Gloveus has stepped down as adm. dir. of ORION PHARMA A/S.
As of September 13, 2005, is registered as an owner of ORION PHARMA A/S with an ownership share of 100%.
As of July 28, 2004, Olli Heikki Huotari has joined the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Pekka Mikael Kaivola has joined the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Jørgen Kjär has left the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Finn Jørgen Jensen has left the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Bo Andersen has left the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Risto Helge Miettunen has left the board of directors of ORION PHARMA A/S.
As of July 28, 2004, Markku Esko Tapani Huhta-Koivisto has left the board of directors of ORION PHARMA A/S.
As of November 1, 2003, Bo Andersen has joined the board of directors of ORION PHARMA A/S.
As of November 1, 2003, Bo Andersen has joined the board of directors of ORION PHARMA A/S.
As of November 1, 2003, Bo Andersen has left the board of directors of ORION PHARMA A/S.
As of November 1, 2003, Kim Bruun Lauenborg has left the board of directors of ORION PHARMA A/S.
As of March 24, 2003, Jari Ilmari Karlson has joined the board of directors of ORION PHARMA A/S.
As of March 24, 2003, Markku Esko Tapani Huhta-Koivisto has joined the board of directors of ORION PHARMA A/S.
As of March 24, 2003, Pasi Uolevi Salokangas has left the board of directors of ORION PHARMA A/S.
As of March 24, 2003, Pauli Juhani Torkko has left the board of directors of ORION PHARMA A/S.
As of September 3, 2002, Bo Creutzer has left the board of directors of ORION PHARMA A/S.
As of September 3, 2002, Tomas Olof Leander Gloveus is registered as adm. dir. of ORION PHARMA A/S.
As of September 3, 2002, Flemming Erik Allan Andersen has stepped down as director of ORION PHARMA A/S.
As of June 14, 2002, Risto Helge Miettunen has joined the board of directors of ORION PHARMA A/S.
As of July 1, 2001, Flemming Erik Allan Andersen is registered as director of ORION PHARMA A/S.
As of June 13, 2001, Kim Bruun Lauenborg has joined the board of directors of ORION PHARMA A/S.
As of June 13, 2001, Kim Bruun Lauenborg has left the board of directors of ORION PHARMA A/S.
As of June 13, 2001, Jørgen Damsbo Andersen has stepped down as adm. dir. of ORION PHARMA A/S.
As of August 11, 2000, Farzad Jahanshahi has left the board of directors of ORION PHARMA A/S.
As of March 23, 2000, Jonas Anders Roland Heierson has joined the board of directors of ORION PHARMA A/S.
As of March 23, 2000, Bo Creutzer has joined the board of directors of ORION PHARMA A/S.
As of March 23, 2000, Jørgen Damsbo Andersen is registered as adm. dir. of ORION PHARMA A/S.
As of March 14, 2000, Jonas Anders Roland Heierson has left the board of directors of ORION PHARMA A/S.
As of March 14, 2000, Lars Ekholm has stepped down as adm. dir. of ORION PHARMA A/S.
As of November 1, 1999, Lars Ekholm is registered as adm. dir. of ORION PHARMA A/S.
As of October 29, 1999, Henning Brømsøe Termansen has left the board of directors of ORION PHARMA A/S.
As of October 29, 1999, Henning Brømsøe Termansen has stepped down as adm. dir. of ORION PHARMA A/S.
As of March 25, 1999, EY Danmark A/S has been appointed auditor of ORION PHARMA A/S.
As of March 25, 1999, LUND THOMSEN & PARTNERE STATSAUTORISEREDE REVISORER has stepped down as auditor of ORION PHARMA A/S.
As of March 25, 1999, Finn Jørgen Jensen has joined the board of directors of ORION PHARMA A/S.
As of March 25, 1999, Farzad Jahanshahi has joined the board of directors of ORION PHARMA A/S.
As of March 25, 1999, Kim Bruun Lauenborg has joined the board of directors of ORION PHARMA A/S.
As of March 25, 1999, Helen Thiberg has left the board of directors of ORION PHARMA A/S.
As of March 25, 1999, Kalevi Pekka Richard Reijonen has left the board of directors of ORION PHARMA A/S.
As of April 1, 1998, Bo Johansen has left the board of directors of ORION PHARMA A/S.
As of April 1, 1998, Jukka Antero Hyppola has left the board of directors of ORION PHARMA A/S.
As of March 9, 1998, LUND THOMSEN & PARTNERE STATSAUTORISEREDE REVISORER has been appointed auditor of ORION PHARMA A/S.
As of March 9, 1998, P.J. AARUP STATSAUTORISEREDE REVISORER I/S has stepped down as auditor of ORION PHARMA A/S.
As of April 11, 1995, Sigurd August Heinrich Kahlke has left the board of directors of ORION PHARMA A/S.
As of April 11, 1995, Tommy Bach Jensing has left the board of directors of ORION PHARMA A/S.
As of April 11, 1995, Lars Gustaf Ekholm has left the board of directors of ORION PHARMA A/S.
As of April 11, 1995, Bent Jørgen Larsen has left the board of directors of ORION PHARMA A/S.
As of March 25, 1994, Olavi Ilkka Reido Larma has left the board of directors of ORION PHARMA A/S.
As of March 13, 1991, Eva Charlotte Lundh has left the board of directors of ORION PHARMA A/S.
As of March 13, 1991, Helen Thiberg has left the board of directors of ORION PHARMA A/S.
As of October 21, 1988, Ove Thorkil Hansson has left the board of directors of ORION PHARMA A/S.
As of July 6, 1988, Ove Thorkil Hansson has stepped down as adm. dir. of ORION PHARMA A/S.
As of March 28, 1988, Michael Frederik Treschow has left the board of directors of ORION PHARMA A/S.
As of March 28, 1988, Michael Frederik Treschow has stepped down as adm. dir. of ORION PHARMA A/S.
As of December 22, 1987, Ove Thorkil Hansson has stepped down as adm. dir. of ORION PHARMA A/S.
As of February 16, 1953, P.J. AARUP STATSAUTORISEREDE REVISORER I/S has been appointed auditor of ORION PHARMA A/S.
As of February 16, 1953, Eva Charlotte Lundh has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Sigurd August Heinrich Kahlke has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Ove Thorkil Hansson has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Helen Thiberg has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Helen Thiberg has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Jørgen Kjär has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Henning Brømsøe Termansen has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Tommy Bach Jensing has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Lars Gustaf Ekholm has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Bo Johansen has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Bent Jørgen Larsen has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Michael Frederik Treschow has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Jukka Antero Hyppola has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Olavi Ilkka Reido Larma has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Pasi Uolevi Salokangas has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Pauli Juhani Torkko has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Kalevi Pekka Richard Reijonen has joined the board of directors of ORION PHARMA A/S.
As of February 16, 1953, Ove Thorkil Hansson is registered as adm. dir. of ORION PHARMA A/S.
As of February 16, 1953, Ove Thorkil Hansson is registered as adm. dir. of ORION PHARMA A/S.
As of February 16, 1953, Henning Brømsøe Termansen is registered as adm. dir. of ORION PHARMA A/S.
As of February 16, 1953, Michael Frederik Treschow is registered as adm. dir. of ORION PHARMA A/S.
ORION PHARMA A/S was founded on February 16, 1953.
Companies in the same industry and area
CVR 41722460
CVR 39371049
CVR 39503778
CVR 40873309
CVR 31774284
